A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Popularity Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.
Several professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has taken down problematic content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.
After minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.
Item Information and Pricing
Inside these communities, messages display dark colored parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they can’t verify. Although the research behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to possibly significant medical dangers”.
